focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,771.00
Ask: 1,771.50
Change: -8.50 (-0.48%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Former Tencent employees, including Alibaba exec, held in China graft probe

Fri, 10th Jul 2015 10:42

(Adds latest statements from companies, details)

By Paul Carsten and Arathy S Nair

BEIJING/BENGALURU, July 10 (Reuters) - Chinese authoritieshave detained about half a dozen former employees of TencentHoldings Ltd for alleged corruption and bribery, aswell as a current Alibaba Group Holding Ltd executive,the two companies said.

Amid a continuing crackdown on corruption by ChinesePresident Xi Jinping, Tencent said in a statement on Friday"five or six" people were detained, including two surnamed Zhangand Yue.

"An internal investigation brought to light bribery andcorruption among some online video employees ... The police havebeen notified and we are waiting for the results," the companysaid in a previous statement.

The alleged wrongdoing occurred when current Alibabaexecutive Patrick Liu was heading the social networking andentertainment firm's online video unit, according to Tencent.

An Alibaba spokeswoman said late on Thursday that Liu wastaken into custody by the Public Security Bureau.

Liu could not be reached for comment.

E-commerce giant Alibaba and Tencent, China's biggest socialnetworking and entertainment firm, are the country's two biggestInternet companies. The two have clashed with increasingfrequency as they move away from their core businesses and bothpush into areas like online entertainment, spending hundreds ofmillions of dollars on video streaming platforms and music.

"We understand Patrick Liu with our digital entertainmentunit has been detained by the authorities," Alibaba spokesmanBob Christie said in an email. "This issue is related to histime at Tencent and has nothing to do with Alibaba."

Liu and other former members of Tencent's video businessleft the company in 2013 and joined Alibaba later that year.

Tencent and Liu went to court in 2014 over a contractdispute concerning a confidentiality and non-compete agreementwhich Liu unsuccessfully tried to appeal against, according toofficial Chinese court records.

Alibaba said on its official Weibo microblog it was"extremely shocked" by the detention of Liu, who is also anexecutive director at Alibaba Pictures Group Ltd.

Alibaba has arranged for Liu's duties to be handled in hisabsence to protect Alibaba Pictures' shareholders, will providehim with legal support and that young people make mistakes, thecompany said.

"Patrick Liu was a former member of Tencent's management,and is suspected of corruption while in his position - this farexceeds the boundaries of making mistakes and violated thecompany's rules, as well as violating the law," Tencent said inits own Weibo post on Friday.

"Making mistakes can be forgiven, but how can breaking thelaw be tolerated?" (Editing by Stephen Coates and Kenneth Maxwell)

More News
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.